JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
There are no items in your shopping cart
Featured Products
Axon 1338
CAS [477600-75-2]
MF C16H20N6OMW 312.37
Janus Kinase 3 (JAK3) inhibitor; an immunosuppressive agent exhibiting potent effects in preclinical transplantation and arthritis models; clinically safe and effective in preventing transplant rejection and improving symptoms of rheumatoid arthritis and psoriasis.This product is also available as its citrate salt form, Tofacitinib citrate (Axon 2072).
KEYWORDS: CP 690550 | supplier | JAK3 inhibitor | Tasocitinib | Tofacitinib | CP690550 | CP-690550 | CAS [477600-75-2] | JAK-STAT Pathway | JAK | Janus Kinase | immunosuppressive | transplantation | rheumatoid | arthritis | rejection | psoriasis
List of publications using CP 690550 (Axon 1338) purchased from Axon Medchem
3-{(3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile
[477600-75-2]
The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.
Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!
* Required Fields